GNE-375;7H-Pyrrolo[2,3-c]pyridin-7-one, 6-(2E)-2-buten-1-yl-4-[2,5-dimethoxy-4-(4-morpholinylcarbonyl)phenyl]-1,6-dihydro-2-methyl-;GNE-375, 10 mM in DMSO;(E)-6-(But-2-en-1-yl)-4-(2,5-dimethoxy-4-(morpholine-4-carbonyl)phenyl)-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one
GNE-375 is a potent and highly selective BRD9 inhibitor (IC50 = 5 nM) with over 100-fold selectivity over BRD4, TAF1, and CECR2; it reduces BRD9 binding to chromatin.